Amgen Inc. buy Royal Bank of Canada
Start price
07.08.24
/
50%
€284.90
Target price
07.08.25
€331.19
Performance (%)
2.09%
Price
17:13
€290.85
Summary
This prediction is currently active. With a performance of 2.09%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. This prediction currently runs until 07.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Amgen Inc. | 2.09% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $332.00 to $362.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat